Overview

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Status:
NOT_YET_RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.
Phase:
PHASE2
Details
Lead Sponsor:
Inova Health Care Services
Treatments:
Deferasirox
Deferiprone
Deferoxamine
Echocardiography
Electrocardiography